OGEN vs PSA · rev $37.7K vs rev $4.82B
Oragenics Inc (OGEN) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
PSA (PSA) common stock.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
OGEN currently screens at market cap $2.7M. PSA currently screens at market cap $0.
Not investment advice. Open the OGEN and PSA stock pages for the full models.
Not investment advice.